Last reviewed · How we verify
IPV ID Device
At a glance
| Generic name | IPV ID Device |
|---|---|
| Also known as | Intradermal Inactivated Poliovirus Vaccine using intradermal device |
| Sponsor | London School of Hygiene and Tropical Medicine |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- IPV Clinical Trial - The Gambia (PHASE4)
- ID Administration of fIPV Using Intradermal Adapters vs. BCG Syringe (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IPV ID Device CI brief — competitive landscape report
- IPV ID Device updates RSS · CI watch RSS
- London School of Hygiene and Tropical Medicine portfolio CI